Prevention of Severe Hypoglycemia in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

September 30, 2004

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

insulin glargine

DEVICE

continuous subcutaneous insulin infusion

Trial Locations (1)

NE4 6BE

Newcastle Diabetes Centre, Newcastle

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

collaborator

Newcastle Primary Care Trust

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Newcastle University

OTHER